Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection - Wikidata - awgldk - TriplyDB

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection

http://www.wikidata.org/entity/Q34146893

about

Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases Helminth infections and host immune regulation Purinergic signaling in schistosomal infection Developmentally regulated expression, alternative splicing and distinct sub-groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL) gene family.Posttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses.[Epidemiological characteristics and geographical distribution of schistosomiasis and geohelminths, in the State of Sergipe, according to data from the Schistosomiasis Control Program in Sergipe].Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.Hepatic stellate cells and parasite-induced liver fibrosis.IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.Worms and allergy.Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation.Immunology of human schistosomiasis.Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis?The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.Immunopathology of schistosomiasis Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection.T-helper 17 cells are associated with pathology in human schistosomiasis.Schistosome egg antigens elicit a proinflammatory response by trophoblast cells of the human placenta Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ Myrrh and artesunate modulate some Th1 and Th2 cytokines secretion in Schistosoma mansoni infected mice Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin.Monocyte subsets in schistosomiasis patients with periportal fibrosis IL-13 Signaling in Liver Fibrogenesis The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.Host regulation of liver fibroproliferative pathology during experimental schistosomiasis via interleukin-4 receptor alpha Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes?Recombinant Sj16 from Schistosoma japonicum contains a functional N-terminal nuclear localization signal necessary for nuclear translocation in dendritic cells and interleukin-10 production.Elevated serum antibody against Schistosoma japonicum HSP60 as a promising biomarker for liver pathology in schistosomiasis.Schistosoma mansoni major egg antigen Smp40: molecular modeling and potential immunoreactivity for anti-pathology vaccine development.[Schistosoma-associated chronic septicemic salmonellosis: evolution of knowledge and immunopathogenic mechanisms].Receptor Antagonist of IL-13 Exerts a Potential Negative Regulation During Early Infection of Human Schistosomiasis.Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin.Paeoniflorin ameliorates schistosomiasis liver fibrosis through regulating IL-13 and its signalling molecules in mice.Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.

P2860

Q26779081-BB9BBF8A-18AF-4A94-9162-3ACCC6A49587 Q26829956-D7859DEB-2583-44B9-B598-F13975D8755F Q28073072-48C212CA-11A1-4CB5-AB52-27E593106B2A Q33320897-B1C47679-D1FC-496E-883C-AB267A24D2E6 Q33596079-A40948D1-7120-41C0-84A3-C8C29DC538A9 Q33826342-45CF2A30-FBEB-4DD5-89A4-E6EFD12782D8 Q34017976-170A87C3-9718-493F-9558-E6A5B0A10C66 Q34043746-2474E92A-D37C-48A3-9974-76C374BBFB52 Q34064182-EF5025B3-5E13-4695-A87F-2C9A24F1F5BD Q34334214-D8F1B442-6022-462E-8A9C-D8D8EF9CB05F Q34500862-608D6267-2687-410C-AE01-24FD82B7F9CA Q34565147-986C050F-D706-4BA1-A8BC-92B3B5EDAB1B Q34740114-A562919E-285E-448F-AB99-A7DFEE2DF8FA Q34782228-4064A9C7-9D7C-4EA2-B176-C2E6B866DCA9 Q35088439-6461B876-8BF1-480B-B2EF-9D5816594DB1 Q35101462-A3ACC87A-7ADD-411F-8156-0D18251391F1 Q35222060-DB32C45A-04B3-476A-8806-DB06D27B27ED Q36220509-97912B36-0731-40AA-85E7-39263EFCC366 Q36520002-1FA55CC3-3C04-4FB4-9C9F-FBAAFC455473 Q36606601-6C083646-6531-428A-8025-86282C9DF48B Q36646777-DA10358C-9DE9-414F-8219-57CD15A23015 Q36803942-D5E0391E-FADE-4872-98EC-1460DA46EFA1 Q37026406-519C20E6-844E-415D-8537-1E58BC1DDF87 Q37140597-10C3DA2A-5DD0-4618-B408-2BE3AB2C612E Q37365765-3D1169E1-4713-427C-AE71-C8B86411847E Q37371070-BE0C86D3-9D3B-4B97-99E8-6CF3851A8328 Q37686798-BD9BEF12-43FE-4BDC-A7AB-1BAD02D635BA Q38010706-4D710186-F1EB-41D1-9333-087E93CDDDF7 Q38254734-5B7056D9-365E-463B-A4AB-7FF944E73310 Q38615196-35F559B3-5C7E-4FAB-B36A-F73F3C9A17FB Q39012899-407D45DA-A2B6-462E-BE25-D421641243B4 Q39498673-1FF5B8CB-CACF-4E48-BA89-5BB23BB5AFE5 Q40097840-F998FADA-1443-482C-8B06-FC91A195D842 Q40291372-6C43EF11-5905-445F-BE1C-067674C67A89 Q40378031-E124CD29-D47B-4BB0-9272-12906C380B71 Q40485925-410ADFF8-AA52-4198-A247-06244CB26AAD Q40547961-953B49FD-BC7C-4372-A396-068253A5C012 Q43096273-676A2D3F-A0B0-46DF-8A34-008F15837378 Q43568745-8BD22D88-2FC2-4942-9F1C-4050B2B51975 Q51737857-A9EA9583-7B99-4AEA-BE73-8D4F9B74FE84

P2860

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection

http://www.wikidata.org/entity/Q34146893

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Association of type 2 cytokine ...... Schistosoma mansoni infection

@ast

Association of type 2 cytokine ...... Schistosoma mansoni infection

@en

Association of type 2 cytokine ...... Schistosoma mansoni infection

@nl

type

label

Association of type 2 cytokine ...... Schistosoma mansoni infection

@ast

Association of type 2 cytokine ...... Schistosoma mansoni infection

@en

Association of type 2 cytokine ...... Schistosoma mansoni infection

@nl

prefLabel

Association of type 2 cytokine ...... Schistosoma mansoni infection

@ast

Association of type 2 cytokine ...... Schistosoma mansoni infection

@en

Association of type 2 cytokine ...... Schistosoma mansoni infection

@nl

P1433

Q34146893-A213E498-3F6A-4DE2-A3E3-DBA5AD2FB4C5

P1476

Q34146893-2AD7B150-885D-4ADE-ADF3-8D2B5DC20EDA

P2093

Q34146893-0D0B2375-361E-467F-9FA7-F541EB8748EC

Q34146893-663C484B-F0A0-4D08-B99E-B3182FF800B9

Q34146893-7D147FAF-3AB8-473D-8E9F-F0688E77285D

Q34146893-7E31D56C-D7CC-4113-BF94-8FA42D31435A

Q34146893-80B85183-B384-4E04-8DAA-BDA98CA63234

Q34146893-93484751-4A93-4C16-8A58-06F786DBBED0

Q34146893-9E4B1F08-A97F-4620-8C8C-4235F589EC8C

Q34146893-B910B803-71B1-427E-BC36-61959A7C41AB

Q34146893-D79FC1EE-FD52-493E-8499-980983555844

Q34146893-F50B9E0E-F878-48C3-89CF-049DA4B19327

P2860

Q34146893-04A913CE-2FCD-4896-92F7-98F789B6C2B4

Q34146893-0984A2FC-9A73-4DD8-8F17-BD3CD859F60A

Q34146893-20BEC3FE-1860-4270-AAB6-ABDD2855F740

Q34146893-26938720-1AF0-4295-970E-FDA5AAE8E92D

Q34146893-28AD0CCD-685D-4D5B-8A9A-E243F2373DAC

Q34146893-4F6FF9CA-905D-4ED3-A9B0-D33A7550023F

Q34146893-55696910-D723-431F-A1DF-F19B6C2E6D17

Q34146893-67439160-7269-46D2-A430-4E9D6D497521

Q34146893-74D36123-1EB4-4A8A-85A8-067D07B992DD

Q34146893-7972D6F6-3DD2-477F-9CC1-399E5991BE53

P304

Q34146893-1FF32018-653C-4DBA-9C5F-F35E2EA4572B

P31

Q34146893-5F3B3C70-B1F4-498C-93B7-C5D9172B4A2C

P356

Q34146893-251C1B8C-67AA-40CC-90A4-BAC8483C996F

P407

Q34146893-07ED8429-065F-487D-9A4A-C6C5A515CE95

P433

Q34146893-D7E17768-A846-434A-9C6C-F63E23E64A45

P478

Q34146893-D43C6A2E-80E7-426B-82E5-FCB4965C2332

P5008

Q34146893-E3A3584F-5CAF-4293-8C9B-7351F34FD88A

P577

Q34146893-92275CB5-C63C-445A-9F40-9E36679DA744

P5875

Q34146893-B3E9C220-E26B-4E3A-89EB-3334D5A9B3B5

P698

Q34146893-F01D8268-4A45-46CA-AA47-A41A3D2C5D60

P921

Q34146893-7C6ED0BD-20F6-43ED-9F90-C3A457DE08CD

P932

Q34146893-11605769-CF5D-4406-B881-C35FB6DB5D27

P356

IAI.72.6.3391-3397.2004

P1433

Infection and Immunity

P1476

Association of type 2 cytokine ...... Schistosoma mansoni infection

@en

P2093

Adriana Almeida de Jesus

http://www.w3.org/2001/XMLSchema#string

Amélia Ribeiro de Jesus

http://www.w3.org/2001/XMLSchema#string

Andréa Magalhães

http://www.w3.org/2001/XMLSchema#string

Angela Silva

http://www.w3.org/2001/XMLSchema#string

Delfin Gonzalez Miranda

http://www.w3.org/2001/XMLSchema#string

Edgar M Carvalho

http://www.w3.org/2001/XMLSchema#string

Edward Pearce

http://www.w3.org/2001/XMLSchema#string

Luciana B Santana

http://www.w3.org/2001/XMLSchema#string

Maria Ilma Araújo

http://www.w3.org/2001/XMLSchema#string

Roberval Gonzalez Miranda

http://www.w3.org/2001/XMLSchema#string

P2860

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Hepatic schistosomiasis.

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

The pathophysiology of falciparum malaria.

Pathophysiology and pathogenesis of hepatosplenic schistosomiasis mansoni.

Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

The schistosomiasis problem in the world: results of a WHO questionnaire survey.

Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures.

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender.

P304

3391-3397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.72.6.3391-3397.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8550015

http://www.w3.org/2001/XMLSchema#string

P698

15155645

http://www.w3.org/2001/XMLSchema#string

P921

Schistosoma mansoni

P932

415716

http://www.w3.org/2001/XMLSchema#string